Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03190915
Title Trametinib in Treating Patients With Relapsed or Refractory Juvenile Myelomonocytic Leukemia
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors National Cancer Institute (NCI)
Indications

juvenile myelomonocytic leukemia

Therapies

Trametinib

Age Groups: adult child

Additional content available in CKB BOOST